-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.33764.02% Upside
Cabaletta Bio, Inc. Frequently Asked Questions
-
What analysts cover Cabaletta Bio, Inc.?
Cabaletta Bio, Inc. has been rated by research analysts at Stifel Nicolaus, Wells Fargo, Morgan Stanley in the past 90 days.